JOHN J. KENNY; WILLIAM C. MOLONEY, F.A.C.P.
Multiple myeloma, except for the so-called "solitary" type, is considered to be an inevitably fatal disease of relatively short duration and, in the main, little influenced by therapy. In reviewing all cases of myeloma reported in the literature from 1848 to 1928, Geschicter and Copeland1 noted that, in 425 cases, the longest survival was five years, with the average under two years. In several subsequent reports on large series of cases2, 3, 4, 5, 6, 7 the average duration of life after the onset of symptoms was from one and one-half to two years. Experience with a series of 57
KENNY JJ, MOLONEY WC. LONG-TERM SURVIVAL IN MULTIPLE MYELOMA: REPORT OF THREE CASES1. Ann Intern Med. ;45:950–957. doi: 10.7326/0003-4819-45-5-950
Download citation file:
Published: Ann Intern Med. 1956;45(5):950-957.
Hematology/Oncology, Multiple Myeloma.
Results provided by:
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use